ProPhase Labs Inc (NASDAQ:PRPH) has a beta value of -0.36 and has seen 0.4 million shares traded in the recent trading session. The company, currently valued at $10.83M, closed the recent trade at $0.45 per share which meant it lost -$0.01 on the day or -1.35% during that session. The PRPH stock price is -1562.22% off its 52-week high price of $7.48 and 8.89% above the 52-week low of $0.41. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.34 million shares traded. The 3-month trading volume is 311.18K shares.
The consensus among analysts is that ProPhase Labs Inc (PRPH) is Hold stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 1 have rated it as a Hold, with 0 advising it as a Buy. 0 have rated the stock as Underweight.
ProPhase Labs Inc (NASDAQ:PRPH) trade information
Sporting -1.35% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the PRPH stock price touched $0.45 or saw a rise of 22.98%. Year-to-date, ProPhase Labs Inc shares have moved -40.06%, while the 5-day performance has seen it change -11.21%. Over the past 30 days, the shares of ProPhase Labs Inc (NASDAQ:PRPH) have changed -27.52%. Short interest in the company has seen 0.15 million shares shorted with days to cover at 7.04.
Wall Street analysts have a consensus price target for the stock at $14, which means that the shares’ value could jump 96.79% from the levels at last check today. The projected low price target is $14.0 while the price target rests at a high of $14.0. In that case, then, we find that the latest price level in today’s session is -3011.11% off the targeted high while a plunge would see the stock gain -3011.11% from the levels at last check today.
ProPhase Labs Inc (PRPH) estimates and forecasts
Figures show that ProPhase Labs Inc shares have underperformed across the wider relevant industry. The company’s shares have lost -85.36% over the past 6 months, with this year growth rate of -25.51%, compared to 17.30% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -47.90% over the past 5 years.
PRPH Dividends
ProPhase Labs Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
ProPhase Labs Inc (NASDAQ:PRPH)’s Major holders
Insiders own 14.34% of the company shares, while shares held by institutions stand at 7.63% with a share float percentage of 8.91%. Investors are also buoyed by the number of investors in a company, with ProPhase Labs Inc having a total of 39.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 0.66 million shares worth more than $2.74 million. As of 2024-06-30, VANGUARD GROUP INC held 3.6351% of shares outstanding.
The other major institutional holder is RENAISSANCE TECHNOLOGIES LLC, with the holding of over 0.22 million shares as of 2024-06-30. The firm’s total holdings are worth over $0.92 million and represent 1.222% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. As of Sep 30, 2024, the former fund manager holds about 1.90% shares in the company for having 454.64 shares of worth $0.21 million while later fund manager owns 181.39 shares of worth $83058.0 as of Sep 30, 2024, which makes it owner of about 0.76% of company’s outstanding stock.
